Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer
Clinical trial NCT06276868 · RECRUITING
Trial details
- NCT number
- NCT06276868
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-20
- Primary completion
- 2025-07-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.